Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study
- 1 July 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9174) , 197-202
- https://doi.org/10.1016/s0140-6736(98)10175-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-upEuropean Journal of Cancer and Clinical Oncology, 1991
- Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.Journal of Clinical Oncology, 1991
- Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patientsCancer, 1989
- The Relationship Between Micrometastases in the Bone Marrow, Histopathologic Features of the Primary Tumor in Breast Cancer and PrognosisAmerican Journal of Clinical Pathology, 1988
- Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patientsCancer, 1988
- Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrowBreast Cancer Research and Treatment, 1988
- Monoclonal Antibodies Detect Occult Breast Carcinoma Metastases in the Bone Marrow of Patients with Early Stage DiseaseThe American Journal of Surgical Pathology, 1988
- Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.BMJ, 1987
- DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCERThe Lancet, 1983
- Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigenBritish Journal of Cancer, 1981